File(s) not publicly available
Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells
journal contribution
posted on 2023-02-10, 02:12 authored by Y Zhu, KY Chew, M Wu, AC Karawita, G McCallum, LE Steele, A Yamamoto, LI Labzin, T Yarlagadda, AA Khromykh, X Wang, JDJ Sng, CJ Stocks, Y Xia, TR Kollmann, D Martino, M Joensuu, FA Meunier, G Balistreri, H Bielefeldt-Ohmann, AC Bowen, A Kicic, Peter Sly, KM Spann, KR ShortChildren typically experience more mild symptoms of Coronavirus Disease 2019 (COVID-19) when compared to adults. There is a strong body of evidence that children are also less susceptible to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection with the ancestral viral isolate. However, the emergence of SARS-CoV-2 variants of concern (VOCs) has been associated with an increased number of pediatric infections. Whether this is the result of widespread adult vaccination or fundamental changes in the biology of SARS-CoV-2 remain to be determined. Here, we use primary nasal epithelial cells (NECs) from children and adults, differentiated at an air–liquid interface to show that the ancestral SARS-CoV-2 replicates to significantly lower titers in the NECs of children compared to those of adults. This was associated with a heightened antiviral response to SARS-CoV-2 in the NECs of children. Importantly, the Delta variant also replicated to significantly lower titers in the NECs of children. This trend was markedly less pronounced in the case of Omicron. It is also striking to note that, at least in terms of viral RNA, Omicron replicated better in pediatric NECs compared to both Delta and the ancestral virus. Taken together, these data show that the nasal epithelium of children supports lower infection and replication of ancestral SARS-CoV-2, although this may be changing as the virus evolves.
History
Journal
PLoS BiologyVolume
20Pagination
e3001728-e3001728Location
United StatesPublisher DOI
ISSN
1544-9173eISSN
1545-7885Language
enPublication classification
C1 Refereed article in a scholarly journalEditor/Contributor(s)
Sugden BIssue
8Publisher
Public Library of Science (PLoS)Usage metrics
Categories
No categories selectedKeywords
AdultCOVID-19ChildEpithelial CellsHumansSARS-CoV-2PneumoniaLungPreventionPneumonia & InfluenzaBiodefenseEmerging Infectious DiseasesInfectious DiseasesVaccine RelatedPediatric2 Aetiology2.1 Biological and endogenous factorsInfection3 Good Health and Well BeingBiological SciencesAgricultural and Veterinary SciencesMedical and Health Sciences
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC